NCT00514267View on ClinicalTrials.gov

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Prostate CancerTumors
Interventions
DRUG

YM 155

IV

DRUG

Docetaxel

IV

DRUG

Prednisone

Oral

Trial Locations (1)

78229

San Antonio

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY